Half your marketing never gets used

It's great to be here. Thanks for inviting me. I look forward to the the process.

Okay. well I'll I'll try to keep it very short because it's I've been around a while. So the gist of it is I I have a a background from when I got graduated from university in I went into publishing. I was in publishing for about twenty five years. I started out in educational publishing with IBM and then moved over to regular what I call consumer based publishing. with in the how-to market and I was working for Time Warner and I ended up with a company called Sunset that is out of the West Coast here in the United States. and I became their national account manager. And then after that I started managing other companies that were in the publishing area. And in twenty in two thousand took a company that we'd gone from five million to twelve million and we sold that company. and I moved from the Arizona at that point back to Southern California and I formed a company called ScMX Development where I worked specifically with doctors who wanted to have their practices run properly. So I put all of their procedures together. I did that for 16 years. I ended up with 50 employees, 10 part time employees, and then 12 doctors under contract. I sold that company in 2016, became a CEO consultant with a company called Vistige Worldwide that's based out of San Diego. They have about 50,000 members worldwide, and I was the chair for them for eight years. In the meantime, I formed this company called Forever North Partners with a person who I've met by the name of Dr. Eric Reese. We are in the what they call the life sciences area, and we are specifically in what we call commercialization. So we can take a company's process. all the way from clinical trials through to market and show them how to do that. We now have established a new product called Marwok M-A-R-WALC, which is a AI agent in the market and the sales of the commercialization. So that brings you up to where I am right now.

The expansion what what I'm doing in Forever North Partners as opposed to to CMX development was that CMX development was basically oriented to working with private practitioners in their operations. So we didn't do anything in the market medical side obviously. We did everything from the hiring people, putting all the the the the payrolls in place, their HR in place, putting accounting in place, doing all their buying, building out their facilities. I built out fifteen different medical practice offices in that time. Forever North Partners is a strictly commercialization. So when I got together with my business partner, we looked at what we're being asked to do by various drug and medical device companies. And in that we found that we needed to put together certain other things. So rather than just the sales and marketing side, which he and I are pretty much expert at, we just we saw that we needed to do the entire commercialization spectrum. So we brought on a person who in fact I did a drug discovery I had a we did a drug development clinical trials company that I worked I for about four years until COVID hit when when we weren't be able to see any new patients. So that kind of That kind of took us down to where we couldn't work that that particular business was called the court clinical management. But anyway, I have a a PhD in in that area who run all the clinical trials for me. And so we put her in. We also put our IT person involved because they have to protect the data. And then I brought in a intellectual properties attorney because we're talking about with companies who are putting literally billions of dollars. into a product and they want to make sure it's protected and that not the the information is not getting out in correctly or that they have it protected properly. And then I have a sales force as well involved. And I have a regulatory person for drug drug and medical devices because it's an area that's highly regulated, both in the United States and in Europe. And the person I hired had both both of those areas. covered for us. So anyway, we took it from a very narrow marketing and sales to a full commercialization oper operation. Which w W CMX didn't do. CMX is basically just a a you know, a management group group.

You know, it's really a good question. Really a good question because that's what my our Marwok application solves. we did a lot of research in this area ahead of time. we found that well there's variety of of different studies that were done. primarily the largest one was done by Harvard Business Review in this area of of this what you're talking about, this execution, what we're calling execution we call an execution tax, they call it a gap, but th they s they estimated that yearly there's a trillion dollars wasted in that execution of where marketing is putting together their messaging, they're putting together collateral, etc. When it shifts over into the field, over forty to fifty percent of it doesn't get used or gets lost or isn't used properly, etcetera. So our new product basically designed to bridge that whole gap and make sure that marketing is put together properly, but also the right collateral, the right messaging is applied to the right conversation at the right time by the person you're speaking with, so that it's relevant to them. So yeah, it's a really good question because again, it's a very expensive problem, that's lack of execution.

Well, in our case, we have taken our methodology which was called market application approach, market driven application approach, and another one called sales execution. and the other one is called Casmic, which is our our full on spectrum of commercialization, and we apply another term called the thr the three W's and that is where do you go? Who do you see? What do you say? we have placed that into our own neural network in AI with our methodology. So it's very, very protected. You can't just go out and get a and just put in the same kind of information into AI, you know, like if you went into chat GTP and said, I want to know this, this, this, you would not even come close to what our methodology would deliver, right? So I think the proper thing for a company to do is figure out what they really do well and how they do it, their methodology. and then place that into a s I would call it almost a silo so that it can't be replicated outside in a generalized AI model, right? That you would use. you're everybody's familiar with, you know, just putting in whatever they want to put in it and get some pretty good answers out. But are you going to really get down to the granular level with a with a a a good AI agent that you would on a generalized basis. The answer is no. So know how to put your product or your methodology into AI as a as a whole and and test it to make sure that it's delivering how you would deliver it if you were doing it by yourself, right? That you actually get the right answers to the right people. I've found that we've we in fact we've tested it with our methodology against the the our the system out there. And our Marwalk system just is like just way ahead of anything out there. Then it's purposely for that because of our methodology. So anyway, coming back to your original question, using AI is okay, but per I don't want to say necessarily protect, but put it in a place where as that company can put their methodology in it and protect it and so that it really develops and produces the way it should, right? The exact product that you want to give to your consumer.

And it and it does it every time. And it does it every time. It doesn't give you another answer that I could go into AI and I can get a completely another answer.

Yeah, C A L C A S E A A E E C That's how we call it.

Yeah, like I told you, we were looking we were being approached by different companies, but they were a lot of times they're saying, Hey, can you can also help us with this, this, and this? And we're going, Well, we only do this. And so I sat down with my business partner Eric and I said, You know, let's really sit down and look at all the steps in in a commercialization from concept to development, right? Then testing it. making sure that it's I p if once you test it, you know it's working, you put your IP onto it, your intellectual property protection onto it, and then you start doing your marketing, even when you're in your phase two or three or four trial area. And before you get there, because you're gonna start doing that. So yeah, it it it what it it's kind of a yes and a no to your question. It was developed over time, but at the same time it was intentional that we we said, this has got to happen. So once we put that together, we had something that a company could come to us and say, we need to develop this from here to here. Or they could just say, Hey, we only need this piece from you, which is fine. We do that as well. But the genesis was essentially us doing our part and companies coming to you and saying, Hey, but we also need this, this, and this. And we looked at our our our cadre of people that we work with and said, Hey, we can put that together and we so we did that and we put these people into our contractual base.

Well, again, I'm not an AI scientist, so I probably couldn't t answer that on a technical level, only that we know that most of the stuff done in marketing takes about twenty five percent of a if I was to hire a what what we call just a a marketing director and then he had a number of marw excuse me, I I I'm forgetting the term. But but sublings underneath there's a particular term I was searching for. But they would spend just in first of all figuring out what the target is, right? It and then doing research to figure out if that target's valid. They would then spend probably a good twenty-five percent to thirty percent of their time just researching.

And getting information first. The fact that AI can crush that down into minutes rather than weeks is the real crux of it. So that you can now redirect the energy of those people into really going granular into each market segment that they want to attack, and they can do it by salesman by account, not just as a broad spectrum. So to me, that's the power of why AI is working well. We we can get really granular now in delivering exactly what we need to say to a specific person based on that person's needs and experience. But we can cut out that several weeks of research and then also the implementation of it across the whole spectrum of the company organization. that that's phenomenally good. This is what goes back to your question about execution.

Yeah, it's it's to successfully launch our this Marwalk product that I was telling you about right now. We're in the development phase of that. It's testing out very well. It's more of a matter of having it placed on the screen so that a person like yourself could come on and and use it easily. and that it delivers for them, but also that it takes them, like I say, from the mark marketing side all the way through the sales side and then the feedback that goes back in. It's not a CRM. We A CRM tells you what you've done, right? It's a repository of here's all the clients we've talked to, here's the things we've said to them, here's some of our collateral, etc. Here's and we've dumped those guys into an email campaign and we shoot it out there, you know, that kind of thing. Marwk is the other way around. It says, Here here's who you're going to here's where you need to go for this product or service. Here's who you're going to see. Here's what you're going to say to them, and it's going to deliver all that right to the into the hands of the salesperson. But it's all developed from the front forward. Once that happens, we are now in the we're going to trial clinical trials, our own clinical trials on the product. I won't call it clinical trials, but let's call it a pilot. doing pilot testing with five different life science companies, most of them in in California. Once that's done, we will do in first quarter of next year do a full on launch of the program out to everybody and the and we're we're keen mostly on life sciences, but it has application in four or five other areas. So I would say first twelve months, solidify our our our marketplace with the life sciences. The next twenty four months or or by the time we get to twenty four months, we will have done a very good job in and s in that and start moving into about probably about four other areas that are similar in the way they attack the market as far as marketing and sales and that we can apply this across to.

Yeah, they can reach me at John at ForevernP dot com. If they go to our website, it's forevernp.com. And they can take a look at our Casmic system, but they can also look at we have a little information there on the Marwalk system, but that's that's changing right now. There'll be a there'll be a a separate website for Marwalk here in the back the next month. it'll just be M-A-R-W-A-L-C dot ai.

You've been very gracious. I appreciate the opportunity to talk and thank you for your time too.